PDF Archive search engine
Last database update: 25 February at 15:38 - Around 75000 files indexed.
2012;15(Suppl):S57-63 REVIEW ARTICLE Revisiting the Role of Anti-angiogenesis Therapy in Metastatic Breast Cancer CH Kwok Department of Oncology, Princess Margaret Hospital, Hong Kong ABSTRACT Angiogenesis is essential for tumour growth and metastasis, and constitutes an important process in the control of cancer progression.
NKX3.1 NKX3.1 may prove to be a valuable marker to assist in determining prostatic origin in poorly differentiated metastatic carcinomas.
박영석(성균관의대), 오상철(고려의대) 14:30-14:55 25min Immunotherapy for MSI-High Metastatic Colorectal Cancer 14:55-15:20 25min Approaches to MSS-Metastatic CRC 15:20-15:30 10min Q&A Cutting Edge of the Treatment of Metastatic Colorectal Cancer 김선영(울산의대) 임유주(서울의대) 김승태(성균관의대) 좌장 :
A Rare Case Report Of Coexisting Mutually Exclusive KRAS And BRAF Mutations In A Patient With Metastatic Colon Adenocarcinoma Anusha Vittal MBBS 1, Anup Kasi Loknath Kumar MD, MPH 2 1 Department of Internal Medicine, 2 Division of Medical Oncology, University of Kansas Medical Center, Kansas City, KS Abstract Discussion Background:
10951 (Amendment n2) titled as “Randomized phase II - III study in first line hormonal treatment for metastatic breast cancer with EORTC Exemestane or Tamoxifen in Postmenopausal patients".
16α-[18F]Fluoro-17β-estradiol (18F-FES) has proven to be a promising tracer for in vivo imaging studies of the ER status of primary and metastatic breast cancer.
Medical treatment for advanced and metastatic PCa David Quinn 15.50 – 18.00 Live surgeries 1.
Optimal chemotherapy after curative surgical resection of metastatic colorectal cancer 이명아 (가톨릭의대) 김정호 (서울의대) 40,000원 기타, 업체 참가 50,000원 60,000원 김승태 (성균관의대) 좌장 :
Pretesh Patel, MD UPDATE ON SYSTEMIC THERAPY FOR METASTATIC GASTRIC/GASTROESOPHAGEAL CANCERS Christina Wu, MD Q&A Mihir Shah, MD (Moderator) COFFEE BREAK AND MEET EXHIBITORS SESSION 2 HEPATOBILIARY MALIGNANCIES 10:05-10:20 CHOLANGIOCARCINOMA:
• Apply Level 1 evidence on the use of chemotherapy in men with newly diagnosed metastatic prostate cancer • Apply Level 1 evidence on the use of active surveillance for men with newly diagnosed low or intermediate risk prostate cancer • Apply level 1 evidence on the optimal approach and sequencing of new agents in the management of advanced renal cancer • Apply level 1 evidence on the optimal approach and sequencing of new agents in the management of advanced bladder cancer • Apply level 1 evidence on the optimal approach and sequencing of new agents in the management of advanced testicular cancer WHO SHOULD ATTEND:
firstname.lastname@example.org Abstract Yttrium-90 radioembolization (90Y-RE) is a well-established therapy for the treatment of hepatocellular carcinoma (HCC) and also of metastatic liver deposits from other malignancies.
Upon further examination, Binder and Antoine determined that the 3,000 year old man had died of metastatic cancer.
Abiraterone prolonged PSA recurrence-free survival for patients with metastatic prostate cancer who have failed with first-line ADT and chemotherapy .
Immunotherapy with Immune Check Point Inhibitors of Locally Advanced and Metastatic Non-Small Cell Lung Cancer in 1st and later lines Maurice Perol, FR 10:40-11:10 Coffee break 11:10-11:40 Debate Pro Are all fit patients candidates for 1st-line treatment with Immune Check Point Inhibitors?
Co-Director, Center for Value-Based Insurance Design, University of Michigan Placebos as treatment for metastatic cancer in clinical trials Lowell E.
• Widely disseminated metastatic tumors of adjacent vertebral bodies • Severe osteoporosis • Overt infection of the involved vertebral bodies • Any entity or condition which totally precludes the possibility of successful fusion such as cancer, kidney dialysis, or osteopenia.
Neutrophil counts provide a measure of patient immune status and infection risk, while CTC counts have been found to correlate strongly with tumor metastatic potential, treatment efficacy and overall survival rate.
The study of this patient group revealed 148 metastatic lesions from the 18F-FES-PET/CT imaging.